CALIXAR helps pharmaceutical and biotechnological companies as well as academic life sciences organizations to preserve and resolve the original structure of proteins during target discovery stage.

CALIXAR provides a range of services based on innovative technologies for production, extraction, solubilization, purification, stabilization and crystallization of functional membrane proteins / antigens.

We improve the reliability of targets for a better performance of high throughput screening and structure-based drug design approaches, the production of vaccines, biodrugs and for the development of diagnostic tools.

Financials

Date Type Amount Investors Valuation
06/01/12 Other 1.1M Siparex, Veymont Participations, INPG Enterprise SA Unknown

People